Literature DB >> 20873960

A comparative study of antioxidative activity of calcium-D-glucarate, sodium-D-gluconate and D-glucono-1,4-lactone in a human blood platelet model.

Joanna Saluk-Juszczak1.   

Abstract

D-glucono-1,4-lactone, sodium D-gluconate and calcium D-glucarate are non-toxic glucose derivatives occurring naturally in fruits and vegetables. Calcium D-glucarate is promoted as an orally bioavailability dietary supplement with potential chemopreventive activity without adverse effects. Despite many commercial applications in pharmaceutical and food industries the potential activity mechanisms of glucarate and gluconate are not clear. The purpose of this study was to investigate and compare the effects of these compounds on blood platelets under oxidative stress conditions and to examine their role in thrombin-induced platelet activation. Platelet activation is essential in haemostasis, tumor progression and allergic and non-allergic inflammation, where reactive oxygen species are involved. The antiplatelet and antioxidative activity was studied in vitro by measuring levels of specific oxidative stress markers: thiobarbituric acid reactive substances, superoxide anion, carbonyl groups, 3-nitrotyrosine, protein and low molecular weight thiols. All tested compounds significantly inhibited thrombin-induced arachidonic peroxidation, O₂⁻ⁱ production and also platelet protein oxidation/nitration induced by peroxynitrite, which is a strong oxidant formed intravascularly in vivo. Carbonyl group generation, thiol oxidation and nitrotyrosine formation were significantly decreased in the presence of glucose derivatives. The obtained results demonstrate that tested compounds may be helpful in the prevention of excessive platelet activation through the antioxidant mechanisms. Comparative studies indicate the predominant preventive activity of sodium D-gluconate. In general, the consumption of apples or apple juice as well as oranges, grapefruit and cruciferous vegetables, sources of large amounts of tested derivatives, have beneficial effects on platelets under oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20873960     DOI: 10.3109/09537104.2010.512210

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  7 in total

1.  Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease.

Authors:  Ming Zhan; Irtaza M Usman; Lin Sun; Yashpal S Kanwar
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

2.  Metabolite Profiling of 5'-AMP-Induced Hypometabolism.

Authors:  Zhaoyang Zhao; Anita Van Oort; Zhenyin Tao; William G O'Brien; Cheng Chi Lee
Journal:  Metabolomics       Date:  2014-02-01       Impact factor: 4.290

3.  Metabonomics of d-glucaro-1,4-lactone in preventing diethylnitrosamine-induced liver cancer in rats.

Authors:  Wenlong Yang; Guanlin Zhou; Shubing Zou; Wentao Yang; Aihong Liu; Shuilin Sun; Baogang Xie
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

4.  Polysaccharide monooxygenase-catalyzed oxidation of cellulose to glucuronic acid-containing cello-oligosaccharides.

Authors:  Jinyin Chen; Xiuna Guo; Min Zhu; Chen Chen; Duochuan Li
Journal:  Biotechnol Biofuels       Date:  2019-02-27       Impact factor: 6.040

5.  Rikkunshito Ameliorates Cancer Cachexia Partly through Elevation of Glucarate in Plasma.

Authors:  Katsuya Ohbuchi; Shin Nishiumi; Naoki Fujitsuka; Tomohisa Hattori; Masahiro Yamamoto; Akio Inui; Takeshi Azuma; Masaru Yoshida
Journal:  Evid Based Complement Alternat Med       Date:  2015-09-15       Impact factor: 2.629

6.  Increased metabolite levels of glycolysis and pentose phosphate pathway in rabbit atherosclerotic arteries and hypoxic macrophage.

Authors:  Atsushi Yamashita; Yan Zhao; Yunosuke Matsuura; Kazuaki Yamasaki; Sayaka Moriguchi-Goto; Chihiro Sugita; Takashi Iwakiri; Nozomi Okuyama; Chihiro Koshimoto; Keiichi Kawai; Nagara Tamaki; Songji Zhao; Yuji Kuge; Yujiro Asada
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

7.  Flavonolignans inhibit the arachidonic acid pathway in blood platelets.

Authors:  Michal Bijak; Joanna Saluk-Bijak
Journal:  BMC Complement Altern Med       Date:  2017-08-10       Impact factor: 4.782

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.